期刊文献+

45例肾病综合征患者肾组织c-Jun和c-Fos的表达及意义 被引量:1

Expression and significance of c-Jun and c-Fos in 45 patients with nephrotic syndrome
下载PDF
导出
摘要 目的探讨肾病综合征激素抵抗患者肾脏组织中c-Jun和c-Fos的表达及意义。方法根据糖皮质激素治疗效果将45例原发性肾病综合征患者分为3个组:激素敏感组、激素抵抗组、复发后抵抗组,每组15例。用免疫组织化学方法检测45例原发性肾病综合征患者肾组织中c-Jun和c-Fos的表达,并用计算机图像分析系统对结果进行分析。结果复发后抵抗组和激素抵抗组肾组织中c-Jun和c-Fos含量明显高于激素敏感组(P<0.05);复发后抵抗组肾组织中c-Jun和c-Fos与激素抵抗组之间差异无统计学意义(P>0.05)。结论肾组织中c-Jun和c-Fos的升高可能与原发性肾病综合征激素抵抗有关;检测肾组织中c-Jun和c-Fos表达变化有助于判断预后和调整治疗方案。 Objective To investigate the role of c-Jun and c-Fos in the occurrence of steroid resistant nephrotic syndrome(NS). Methods The 45 patients were divided into 3 groups (steroid sensitive group, steroid resistant group and reoccurrent steroid resistant group) according to the response to the treatment with corticosteroids. The expression of c-Jun and c Fos in renal tissues were tested by immunohistochemistry technique in 45 NS patients before treatment with corticosteroids. Results The expression of c-Jun and c Fos in renal tissues increased markedly in the patients with steroid resistant nephrotic syndrome and reoccurrent steroid resistant nephrotic syndrome groups compared with the steroid sensitive group. There was no significant difference of expression of e- Jun and c-Fos in renal tissues between steroid resistant group and recurrent steroid resistant group. The level of c Jun and e-Fos of recurrent group was significant higher than that of before the recurrent. Conclusion The increase of c-inn arid c Fos level might relate with the steroid resistant in nephrotic syndrome patients,although it is uncertain that change is cause or the result. But the analysis of serum c Jun and c Fos might be beneficial to predict the occurrence of steroid resistance in NS patients.
出处 《重庆医学》 CAS CSCD 北大核心 2010年第1期16-18,共3页 Chongqing medicine
关键词 肾病综合征 c—Jun c—Fos 激素抵抗 nephrotie syndrome c J un c-Fos glucocorticoid resistant
  • 相关文献

参考文献9

  • 1Horwitz KB,Jackson TA,Bain DL,et al. Nuclear receptor coactivtor and corepressor [J]. Mol Endocrinol, 1996,10 (10) : 1167.
  • 2Jennifer R, Timoshanko A, Richard K, et al. Leukocyte- derived interleukin-1β interacts with renal interleukin-1 receptor Ⅰ to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis [J]. AM J Pathol,2004,164(6) :1967.
  • 3Martens C, Bilodeu S, Maira M, et al. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor[J]. Mol Endocrinol, 2005,19 (4) : 885.
  • 4Lane SJ, Adcock IM, Richards D, et at. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes[J]. J Clin Invest, 1998,102(12) : 2156.
  • 5程晓刚,粟永萍,罗成基,刘晓宏.C-Jun蛋白对糖皮质激素受体表达及转录激活能力的影响[J].免疫学杂志,2005,21(B06):106-109. 被引量:2
  • 6乔丽,张耀全,程悦,袁发焕.激素抵抗肾病综合征患者血清IL-1β和TNF-α的变化及意义[J].重庆医学,2006,35(23):2153-2154. 被引量:8
  • 7Bladh LG, Liden J,Dahlman Wright K, et al. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression [J]. Mol Pharmacol, 2005,67 (3) : 815.
  • 8Adeoek IM, Lane SJ, Brown CR, et al. glucoeorticoid receptor-activator protein 1 interaction in steroid-resistant asthma [J]. Exp Med, 1995,182(6) : 1951.
  • 9Cabral AL, Hays AN, Housley PR, et al. Repression of glucocorticoid receptor gene transcription by c-Jun[J]. Mol Cell Endoerinol,2001,175(122) :67279.

二级参考文献18

  • 1管娜,丁洁.儿童肾病综合征激素耐药发生机制研究进展[J].临床儿科杂志,2005,23(4):199-201. 被引量:5
  • 2Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids [ J ]. Immunol Cell Biol, 2001, 79 (4): 376-384.
  • 3Mittelstadt PR, Ashwell JD. Inhibition of AP-1 by the glncocorticoid-inducible protein GILZ [J]. J Biol Chem, 2001,276 (31): 29 603 - 29 610.
  • 4Paul CP, Good PD, Winer I, et al. Effective expression of small interfering RNA in human cells [ J ]. Nat Biotechnol,2002, 20 (5): 505 - 508.
  • 5Zhang J, Hua ZC. Targeted gene silencing by small interfering RNA-based knock-down technology [ J ]. Curr Pharm Biotechnol, 2004, 5 (1): 1 - 7.
  • 6Schule R, Rangarajan P, Kliewer S, et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor [J]. Cell, 1990, 62 (6): 1 217- 1 226.
  • 7Adcock IM, Brown CR, Barnes PJ. Tumour necrosis factor αcauses retention of activated glucocorticoid receptor within the cytoplasm of A549 cells [ J]. Biolchem Biophys Res Commun, 1996, 225 (2): 545- 550.
  • 8Rogatsky I, Logan SK, Garabedian MJ. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun Nterminal kinase [ J ]. Proc Natl Acad Sci USA, 1998,95 (5): 2 050 - 2 055.
  • 9Sousa AR, Lane SJ, Sob C, et al. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation [J]. J Allergy Clin Immunol, 1999, 104 (3 pt 1):565 - 574.
  • 10Bailey S, Hall AG, Pearson AD, et al. The role of AP-1 in glucocorticoid resistance in leukaemia [J]. Leukemia, 2001,15 (3): 391 - 397.

共引文献8

同被引文献23

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部